drugset / Trial / NCT04155879

Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels

NCT04155879

Unknown 300 enrolled Hillel Yaffe Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Atrial fibrillation and inflammation are strongly correlated. The aim of this study is to evaluate whether inflammation markers (alpha Defensin) predict maintenance of sinus rhythm following cardioversion. A secondary aim is to evaluate the role of Colchicine, an anti-inflammatory medication, in reducing the recurrence rate of atrial fibrillation.

Timeline

Start
2019-11
Primary completion
2022-11
Completion
2022-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colchicine Small molecule 0.5 mg

Indications